Overweight Is Highly Prevalent In Children with Type 1 Diabetes And Associates with Cardiometabolic Risk

Journal of Pediatrics

Volumn 156, Issue 6, 2010, Pages 923-929

  van Vliet, Mariska ^a,b   Van der Heyden, Josine C ^c   Diamant, Michaela ^b   Von Rosenstiel, Inès A ^a   Schindhelm, Roger K ^d   Aanstoot, Henk J ^c   Veeze, Henk J ^c  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Diabeter   (Netherlands)

^d ISALA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CARDIOVASCULAR RISK; CHILD; CONTROLLED STUDY; DISEASE DURATION; FAMILY HISTORY; FEMALE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROALBUMINURIA; OBESITY; PREVALENCE; PRIORITY JOURNAL; SMOKING;

ALANINE TRANSAMINASE; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; NETHERLANDS; OBESITY; OVERWEIGHT; PREVALENCE; RISK FACTORS;

EID: 77952293211     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2009.12.017     Document Type: Article

References (46)

1. Dietz W.H. Health consequences of obesity in youth: childhood predictors of adult disease. Pediatrics 101 (1998) 518-525
2. Purnell J.Q., Dev R.K., Steffes M.W., Cleary P.A., Palmer J.P., Hirsch I.B., et al. Relationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the Diabetes Control and Complications Trial. Diabetes 52 (2003) 2623-2629
3. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus: the Diabetes Control and Complications Trial Research Group. N Engl J Med 329 (1993) 977-986
4. Nathan D.M., Cleary P.A., Backlund J.Y., Genuth S.M., Lachin J.M., Orchard T.J., et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353 (2005) 2643-2653
5. Influence of intensive diabetes treatment on body weight and composition of adults with type 1 diabetes in the Diabetes Control and Complications Trial. Diabetes Care 24 (2001) 1711-1721
6. Soedamah-Muthu S.S., Fuller J.H., Mulnier H.E., Raleigh V.S., Lawrenson R.A., and Colhoun H.M. High risk of cardiovascular disease in patients with type 1 diabetes in the UK: a cohort study using the general practice research database. Diabetes Care 29 (2006) 798-804
7. Berenson G.S. Childhood risk factors predict adult risk associated with subclinical cardiovascular disease: the Bogalusa Heart Study. Am J Cardiol 90 (2002) 3L-7L
8. Jarvisalo M.J., Jartti L., Nanto-Salonen K., Irjala K., Ronnemaa T., Hartiala J.J., et al. Increased aortic intima-media thickness: a marker of preclinical atherosclerosis in high-risk children. Circulation 104 (2001) 2943-2947
9. Margeirsdottir H.D., Larsen J.R., Brunborg C., Overby N.C., and hl-Jorgensen K. High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: a population-based study. Diabetologia 51 (2008) 554-561
10. Schwab K.O., Doerfer J., Hecker W., Grulich-Henn J., Wiemann D., Kordonouri O., et al. Spectrum and prevalence of atherogenic risk factors in 27,358 children, adolescents, and young adults with type 1 diabetes: cross-sectional data from the German diabetes documentation and quality management system (DPV). Diabetes Care 29 (2006) 218-225
11. de Simone G., Devereux R.B., Chinali M., Best L.G., Lee E.T., Galloway J.M., et al. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study. Diabetes Care 30 (2007) 1851-1856
12. Morrison J.A., Friedman L.A., and Gray-McGuire C. Metabolic syndrome in childhood predicts adult cardiovascular disease 25 years later: the Princeton Lipid Research Clinics Follow-up Study. Pediatrics 120 (2007) 340-345
13. Silverstein J., Klingensmith G., Copeland K., Plotnick L., Kaufman F., Laffel L., et al. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 28 (2005) 186-212
14. Dhuper S., Cohen H.W., Daniel J., Gumidyala P., Agarwalla V., St Victor R., et al. Utility of the modified ATP III defined metabolic syndrome and severe obesity as predictors of insulin resistance in overweight children and adolescents: a cross-sectional study. Cardiovasc Diabetol 6 (2007) 4
15. Standards of medical care in diabetes-2006. Diabetes Care 29 Suppl 1 (2006) S4-S42
16. Verloove-Vanhorick S.P. Body index measurements in 1996-7 compared with 1980. Arch Dis Child 82 2 (2000) 107-112
17. Fredriks A.M., van Buuren S., Fekkes M., Verloove-Vanhorick S.P., and Wit J.M. Are age references for waist circumference, hip circumference and waist-hip ratio in Dutch children useful in clinical practice?. Eur J Pediatr 164 (2005) 216-222
18. De Man S.A., André J.L., Bachman H., Grobbee D.E., Ibsen K.K., Laaser U., et al. Blood pressure in childhood: pooled findings of six European studies. J Hypertens 9 (1991) 109-114
19. Donaghue K.C., Chiarelli F., Trotta D., Allgrove J., and hl-Jorgensen K. ISPAD clinical practice consensus guidelines 2006-2007 microvascular and macrovascular complications. Pediatr Diabetes 8 (2007) 163-170
20. Kilpatrick E.S., Rigby A.S., and Atkin S.L. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications Trial. Diabetes Care 30 (2007) 707-712
21. Weiss R., Dziura J., Burgert T.S., Tamborlane W.V., Taksali S.E., Yeckel C.W., et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350 (2004) 2362-2374
22. van Vliet M., von Rosenstiel I., Schindhelm R.K., Brandjes D.P., Beijnen J.H., and Diamant M. The association of elevated alanine aminotransferase and the metabolic syndrome in an overweight and obese pediatric population of multi-ethnic origin. Eur J Pediatr 168 (2008) 585-591
23. Rodriguez B.L., Fujimoto W.Y., Mayer-Davis E.J., Imperatore G., Williams D.E., Bell R.A., et al. Prevalence of cardiovascular disease risk factors in US children and adolescents with diabetes: the SEARCH for diabetes in youth study. Diabetes Care 29 (2006) 1891-1896
24. Davis T.M., Bruce D.G., and Davis W.A. Prevalence and prognostic implications of the metabolic syndrome in community-based patients with type 1 diabetes: the Fremantle Diabetes Study. Diabetes Res Clin Pract 78 (2007) 412-417
25. Kahn R., Buse J., Ferrannini E., and Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28 (2005) 2289-2304
26. Pambianco G., Costacou T., and Orchard T.J. The prediction of major outcomes of type 1 diabetes: a 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes Care 30 (2007) 1248-1254
27. Alexander C.M., Landsman P.B., Teutsch S.M., and Haffner S.M. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52 (2003) 1210-1214
28. McGill M., Molyneaux L., Twigg S.M., and Yue D.K. The metabolic syndrome in type 1 diabetes: does it exist and does it matter?. J Diabetes Complications 22 (2008) 18-23
29. Pambianco G., Costacou T., Ellis D., Becker D.J., Klein R., and Orchard T.J. The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes 55 (2006) 1463-1469
30. Colhoun H.M., Otvos J.D., Rubens M.B., Taskinen M.R., Underwood S.R., and Fuller J.H. Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes. Diabetes 51 (2002) 1949-1956
31. Levitan E.B., Song Y., Ford E.S., and Liu S. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med 164 (2004) 2147-2155
32. Selvin E., Coresh J., Golden S.H., Boland L.L., Brancati F.L., and Steffes M.W. Glycemic control, atherosclerosis, and risk factors for cardiovascular disease in individuals with diabetes: the atherosclerosis risk in communities study. Diabetes Care 28 (2005) 1965-1973
33. Schwimmer J.B., Pardee P.E., Lavine J.E., Blumkin A.K., and Cook S. Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation 118 (2008) 277-283
34. van Vliet M., von Rosenstiel I., Schindhelm R.K., Brandjes D.P., Beijnen J.H., and Diamant M. Ethnic differences in cardiometabolic risk profile in an overweight/obese paediatric cohort in the Netherlands: a cross-sectional study. Cardiovasc Diabetol 8 (2009) 2
35. Hinderliter A.L., and Runge M.S. Who's on first? Does hypertension in type I diabetics result from nephropathy or metabolic alterations?. Circulation 104 (2001) 508-510
36. Frontoni S., Bracaglia D., and Gigli F. Relationship between autonomic dysfunction, insulin resistance and hypertension, in diabetes. Nutr Metab Cardiovasc Dis 15 (2005) 441-449
37. Schwab K.O., Doerfer J., Krebs A., Krebs K., Schorb E., Hallermann K., et al. Early atherosclerosis in childhood type 1 diabetes: role of raised systolic blood pressure in the absence of dyslipidaemia. Eur J Pediatr 166 (2007) 541-548
38. Kershnar A.K., Daniels S.R., Imperatore G., Palla S.L., Petitti D.B., Pettitt D.J., et al. Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: the SEARCH for Diabetes in Youth Study. J Pediatr 149 (2006) 314-319
39. Loredana M.M., Neil D.R., Toby P.A., Acerini C.L., Barrett T.G., Cooper J.D., et al. Prevalence of abnormal lipid profiles and the relationship with the development of microalbuminuria in adolescents with type 1 diabetes. Diabetes Care 32 (2009) 658-663
40. Nguyen S., McCulloch C., Brakeman P., Portale A., and Hsu C.Y. Being overweight modifies the association between cardiovascular risk factors and microalbuminuria in adolescents. Pediatrics 121 (2008) 37-45
41. Petitti D.B., Imperatore G., Palla S.L., Daniels S.R., Dolan L.M., Kershnar A.K., et al. Serum lipids and glucose control: the SEARCH for Diabetes in Youth study. Arch Pediatr Adolesc Med 161 (2007) 159-165
42. Purnell J.Q., Hokanson J.E., Marcovina S.M., Steffes M.W., Cleary P.A., and Brunzell J.D. Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial. JAMA 280 (1998) 140-146
43. White N.H., Cleary P.A., Dahms W., Goldstein D., Malone J., and Tamborlane W.V. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr 139 (2001) 804-812
44. Ahmed M.L., Connors M.H., Drayer N.M., Jones J.S., and Dunger D.B. Pubertal growth in IDDM is determined by HbA1c levels, sex, and bone age. Diabetes Care 21 (1998) 831-835
45. Luna R., varez-Vazquez P., Hervas E., Casteras A., Perez M.L., Paramo C., et al. The role of diabetes duration, pubertal development and metabolic control in growth in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 18 (2005) 1425-1431
46. Rohrer T., Stierkorb E., Heger S., Karges B., Raile K., Schwab K.O., et al. Delayed pubertal onset and development in German children and adolescents with type 1 diabetes: cross-sectional analysis of recent data from the DPV diabetes documentation and quality management system. Eur J Endocrinol 157 (2007) 647-653